Connected health and AI provider combine to support lung and thoracic diagnosis

Connected healthcare specialist Wellbeing Software has announced a partnership with US-based artificial intelligence (AI) provider Imbio to provide a way for NHS organisations to use AI to support the diagnosis of patients with chronic lung and thoracic conditions. Algorithms developed by Imbio enable clinicians to analyse a patient's lung density and texture. This includes using advanced computer vision to transform a standard chest CT into a detailed map of lung textures in order to identify cases of interstitial lung disease (ILD) and other fibrotic conditions. Graham Ridgway, CEO at Wellbeing Software, said: "We're committed to giving NHS organisations the best choice when it comes to the adoption of AI and are pleased to welcome Imbio and its pioneering algorithms to the AI Connect Programme and our newly launched AI Market Place, which highlights the different applications of AI we are making available. "Algorithms, such as those created by Imbio, have the ability to drastically improve clinical workloads and patient care, but this only becomes a reality when the technology is matched with existing workflows and practices.